143.53
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
Should You Continue to Hold Charles River Stock in Your Portfolio? - TradingView
Charles River Laboratories International, Inc. (NYSE:CRL) Given Consensus Rating of “Hold” by Brokerages - Defense World
Insider Sell: George Massaro Sells Shares of Charles River Labor - GuruFocus
Charles River Laboratories International (NYSE:CRL) Upgraded at TD Cowen - Defense World
Insider Sell: George Massaro Sells Shares of Charles River Laboratories International Inc (CRL) - GuruFocus
RNA Therapy Clinical Trials Market Top Companies StudyCharles - openPR.com
Charles River (CRL) Receives Upgrade and $179 Price Target | CRL Stock News - GuruFocus
We Think Charles River Laboratories International, Inc.'s (NYSE:CRL) CEO Compensation Package Needs To Be Put Under A Microscope - simplywall.st
Charles River (CRL) Upgraded to Buy Amid Potential Value Unlocki - GuruFocus
TD Cowen Upgrades Charles River Laboratories International to Buy From Hold, Adjusts PT to $179 From $105 - marketscreener.com
Unlocking Value: Strategic Divestitures and Market Leadership at Charles River Labs - TipRanks
Charles River Laboratories to Present at Bank of America Health Care Conference - BioSpace
Cell Banking Outsourcing Market: Executive Briefing & - openPR.com
Understanding Charles River (CRL) Reliance on International Revenue - Yahoo Finance
Human Microbiome Sequencing Market Top PlayersBaseclear - openPR.com
Charles river raises 2025 guidance with focus on NAMs and cost optimization - MSN
William Blair Has Bullish Forecast for CRL Q2 Earnings - Defense World
William Blair Analysts Raise Earnings Estimates for CRL - Defense World
Charles River extends gains as Evercore upgrades after Q1 beat - MSN
Barclays Increases Charles River Laboratories International (NYSE:CRL) Price Target to $155.00 - Defense World
Deutsche Bank lifts Charles River Labs target to $180 By Investing.com - Investing.com Nigeria
Morgan Stanley Cuts Price Target on Charles River Laboratories International to $168 From $184 - marketscreener.com
Barclays Keeps Their Hold Rating on Charles River Labs (CRL) - The Globe and Mail
Charles River surges after Q1 beat, guidance raise - MSN
CRL Q1 Earnings & Revenues Beat Estimates, Stock Rises, '25 View Up - MSN
Evercore ISI lifts Charles River Labs stock rating to Outperform By Investing.com - Investing.com Canada
Charles River Labs Stock Soars On Strategic Review Plan With Elliott: Retail Investors Optimistic - MSN
What 10 Analyst Ratings Have To Say About Charles River - Benzinga
Charles River stock upgraded at Evercore ISI (CRL:NYSE) - Seeking Alpha
Charles River (CRL) Stock Target Price Raised by Barclays Analyst | CRL Stock News - GuruFocus
Charles River (CRL) Target Price Raised by Baird Analyst | CRL S - GuruFocus
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2025 Earnings Call Transcript - Insider Monkey
Jefferies Adjusts Price Target on Charles River Laboratories International to $142 From $100, Maintains Hold Rating - marketscreener.com
What Is Charles River Laboratories International, Inc.'s (NYSE:CRL) Share Price Doing? - Yahoo Finance
Charles River (CRL) Sees Price Target Boost After Positive Q1 Insights | CRL Stock News - GuruFocus
Charles River (CRL) Receives Boost After Q1 Success | CRL Stock News - GuruFocus
Charles River: Q1 Earnings Snapshot - Norwalk Hour
Charles River Laboratories International Inc (CRL) Q1 2025 Earnings Call Highlights: Navigating ... - Yahoo Finance
Evercore ISI lifts Charles River Labs stock rating to Outperform - Investing.com
Charles River Laboratories International (NYSE:CRL) Shares Gap Up on Strong Earnings - Defense World
Deutsche Bank lifts Charles River Labs target to $180 - Investing.com
Charles River Laboratories Reports Q1 2025 Results - TipRanks
Decoding Charles River Laboratories International Inc (CRL): A S - GuruFocus
Health Care Stocks Climb As Companies Show Strong Gains - Finimize
Charles River Labs Stock Soars On Strategic Review Plan With Elliott: Retail Investors Optimistic By Stocktwits - Investing.com India
Charles River announces strategic review including 'examination of various alternatives' - MSN
Charles River Labs reshapes board, plans strategic review By Investing.com - Investing.com Canada
Charles River Labs Q1 2025 slides: Beats expectations, raises guidance amid NAMs transition - Investing.com Canada
Charles River (CRL) Stock Upgraded Following Strong Q1 Results | - GuruFocus
Charles River (CRL) Stock Upgraded Following Strong Q1 Results | CRL Stock News - GuruFocus
Charles River Laboratories International Q1 2025 Earnings Call Transcript - MarketBeat
Charles River to initiate a review amid Elliott stakeIs a sale next? - Investing.com Canada
Charles River agrees with Elliott to add new directors, review business - Reuters
Charles River Laboratories (CRL) Adjusts 2025 Guidance Amid Revenue Decline - GuruFocus
Why Are Charles River Laboratories (CRL) Shares Soaring Today - Yahoo Finance
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):